Statement on Drug User Fees: Enhancing Patient Access and Drug Safety

March 14, 2007
KimWitczakWrittenStatement
46.2 KB

Transparency and openness is the key to restoring the FDA as the world’s ‘gold standard’ in drug approvals and safety.

IssuesHealth
You Might Also Be Interested In
press release
May 14, 2020
Consumer Reports supports bill to strengthen privacy protections for data collected to combat coronavirus
May 7, 2020
Consumer letter opposing COVID liability shield for businesses
April 30, 2020
Coalition letter opposing COVID liability shield for businesses
April 30, 2020
CR letter to Congress — proposals to protect effective antitrust enforcement during COVID-19 disruption